Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06382961
Other study ID # SZUS_231101
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 11, 2023
Est. completion date April 28, 2024

Study information

Verified date May 2024
Source Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to learn how postoperative infusion of dexmedetomidine would influence postoperative delirium in elderly patients undergoing lung surgery. The main questions it aims to answer are : 1. Does postoperative dexmedetomidine reduce the incidence of delirium after lung surgery? 2. Does postoperative dexmedetomidine introduce other medical problems? Researchers will compare dexmedetomidine and sufentanil to see if dexmedetomidine works to reduce delirium. Participants will undergo routine postoperative care: 1. Patient-controlled self anesthesia with sufentanil only or combination of sufentanil and dexmedetomidine 2. Postoperative visit twice a day for at least seven days


Recruitment information / eligibility

Status Completed
Enrollment 287
Est. completion date April 28, 2024
Est. primary completion date March 6, 2024
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: - elective surgery for lobectomy or segmentectomy Exclusion Criteria: - local allergy to anesthetics; - patients with a clear preoperative history of nervous system and mental system diseases or long-term use of sedatives or antidepressants; - history of alcoholism, drug abuse or drug dependence; - have a history of brain surgery or injury; - epilepsy and associated mental and cognitive dysfunction, long-term stress stimulation, or psychological disorders; - sick sinus syndrome, second-degree or greater atrioventricular block or other contraindications for use of a2 adrenergic agonist; - liver and kidney insufficiency.

Study Design


Intervention

Drug:
Dexmedetomidine injection
Combining with 3 µg.kg-1 sufentanil, 3 µg.kg-1 dexmedetomidine is injected through intravenous patient controlled anesthesia pump in a 2 ml bolus with 20 minutes lock-out, and a background infusion rate of 2 ml per hour.
Sufentanil injection
3 µg.kg-1 sufentanil is injected through intravenous patient controlled anesthesia pump in a 2 ml bolus with 20 minutes lock-out, and a background infusion rate of 2 ml per hour.

Locations

Country Name City State
China Kunming Children's Hospital Kunming Yunnan

Sponsors (4)

Lead Sponsor Collaborator
Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd. Dongyuan People's Hospital, Kunming Children's Hospital, Shenzhen People's Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of postoperative delirium Delirium is assessed at 8 am and 8 pm for 3 days after surgery
Secondary Incidence of postoperative nausea and vomiting Assessed twice a day for 7days after surgery
Secondary incidence of postoperative complications Other postoperative complications including including hypotension, hypertension, bradycardia, tachycardia, and hypoxemia Assessed daily for 3 days after surgery
Secondary Pain intensities patient pain assessed using numeric rating scale, ranged from 0 to 11, higher score indicate higher pain intensity Assessed daily at 8 am for 3 days after surgery
See also
  Status Clinical Trial Phase
Completed NCT05690672 - Screening for Delirium in Older Inpatients N/A
Completed NCT04656379 - The Incidence and Risk Factors of Postoperative Delirium
Recruiting NCT04187807 - Efficacy of the Administration of Melatonin 5mg in the Prevention of Delirium in Older Adults Hospitalized in the Emergency Department N/A
Active, not recruiting NCT04654962 - Use of Anesthetic Block for the Prevention of in Hospital Delirium in Patients of the Orthogeriatric Clinical Care Center of the HUFSFB and HUSJI From 2019 - 2020
Completed NCT03485183 - The Effect of White and Pink Noise on Hospitalized Older Adults N/A
Recruiting NCT05815017 - YOOMI: Effect of Gamified Physical Therapy Exercise Software on Inpatient Mobility N/A
Recruiting NCT05694091 - Correlation of Perioperative Brain Metabolites With Postoperative Delirium in Elderly Oral Craniomaxillofacial Surgery Patients
Recruiting NCT06100029 - The Effect of Lavender Essential Oil for Delirium in Elderly Intensive Care Unit Patients: Study Protocol N/A
Not yet recruiting NCT06111300 - Dexmedetomidine Effect on Delirium of Elderly Patients Phase 4
Recruiting NCT05391334 - Early Fall Risk Detection and Fall Prevention Among Inpatients With Delirium
Completed NCT06168773 - Combination of Haloperidol and Magnesium for Delirium Prevention in Critically Ill Elderly Phase 2/Phase 3
Recruiting NCT05280860 - Effect of Bilateral RSB on Postoperative Delirium in Elderly Patients Undergoing Laparoendoscopic Single-site Surgery N/A
Recruiting NCT05857462 - The Impact of Integrated Preoperative Fascia Iliaca Compartment Block in Elderly Hip Fracture N/A
Recruiting NCT04404959 - Perioperative Pain and Delirium in Geriatric Patients With Hip Fracture N/A
Not yet recruiting NCT05819723 - Erector Spinae Block and Incidence of Postoperative Delirium After Hip Fracture Surgeries N/A
Recruiting NCT04393272 - Digital Intelligent Assistant for Nursing Application
Recruiting NCT05158998 - Impact of Propofol Versus Sevoflurane on Incidence of Postoperative Delirium in Elderly Patients After Spine Surgery Phase 4
Not yet recruiting NCT06326372 - The Effect of Intraoperative Hyperoxemia on Postoperative Delirium in Geriatric Patients
Completed NCT03175276 - Informant Questionaire on Cognitive Decline in the Elderly (IQCODE) and Delirium in Geriatric Patients
Recruiting NCT06029244 - Eyecontrol coMmunication Platform for dEliRium manaGemEnt in Intensive Care Units (EMERGE) N/A